Skip to main content

Cryptosporidium species and subtypes identified in human domestic cases through the national microbiological surveillance programme in Sweden from 2018 to 2022



The intestinal protozoan parasite Cryptosporidium is an important cause of diarrheal disease worldwide. A national microbiological surveillance programme was implemented in Sweden in 2018 in order to increase knowledge of the molecular epidemiology of human cryptosporidiosis to better understand transmission patterns and potential zoonotic sources. This article summarises the results of the first five years of the surveillance programme.


Cryptosporidium-positive faecal and DNA samples from domestically acquired infections were collected from clinical microbiological laboratories in Sweden. Species and subtype determination was performed using 60 kDa glycoprotein and/or small subunit ribosomal RNA gene analysis.


Between 2018 and 2022, 1654 samples were analysed and 11 different species were identified: C. parvum (n = 1412), C. mortiferum (n = 59), C. hominis (n = 56), C. erinacei (n = 11), C. cuniculus (n = 5), C. meleagridis (n = 3), C. equi (n = 2), C. ubiquitum (n = 2), and one each of C. canis, C. ditrichi and C. felis. Subtyping revealed seven subtype families of C. parvum (new subtype families IIy and IIz) and 69 different subtypes (11 new subtypes). The most common C. parvum subtypes were IIdA22G1c, IIdA24G1, IIdA15G2R1 and IIaA16G1R1b. For C. hominis, four different subtype families and nine different subtypes (two new subtypes) were identified. For additional species, two new subtype families (IIIk and VId) and nine new subtypes were identified. All successfully subtyped C. mortiferum cases were subtype XIVaA20G2T1, confirming previous findings in Sweden. Several outbreaks were identified of which the majority were foodborne and a few were due to direct contact with infected animals.


Infection with C. parvum is the leading cause of human cryptosporidiosis acquired in Sweden, where more than 90% of domestic cases are caused by this zoonotic species and only a small proportion of cases are due to infection with other species. The rodent-associated C. mortiferum is considered an emerging zoonotic species in Sweden and the number of domestically acquired human cases has surpassed that of infection with C. hominis. A high diversity of species and subtypes, as well as diversity within the same subtype, was detected. Also, cryptosporidiosis appears to affect adults to a great extent in Sweden.

Peer Review reports


Cryptosporidium spp. are protozoan parasites that can cause disease in both humans and animals. To date, 21 species and two genotypes have been reported in humans [1,2,3]. The majority of human cases are caused by either Cryptosporidium parvum or Cryptosporidium hominis, which are responsible for more than 95% of infections in humans worldwide [2, 4]. These two species differ in host range and global distribution whereby infection with C. parvum has a broader host range including ruminants, primates, equine animals and rodents, whereas C. hominis is mainly restricted to humans and other primates and equine animals [4]. Other species that cause infection in humans include Cryptosporidium mortiferum, previously known as Cryptosporidium chipmunk genotype I, Cryptosporidium meleagridis, Cryptosporidium cuniculus, Cryptosporidium ubiquitum, Cryptosporidium canis, Cryptosporidium felis, Cryptosporidium viatorum [3, 4] and the relatively recently described Cryptosporidium ditrichi [5].

Cryptosporidiosis in humans usually presents with self-limiting diarrhoea, but the disease can be severe, especially in immunocompromised individuals [6]. However, persisting long-term gastrointestinal symptoms such as diarrhoea, abdominal pain, nausea, fatigue and headache have been reported as well as a possible connection to the onset of inflammatory bowel disease and microscopic colitis [7,8,9,10,11,12]. Thus far, no effective treatment or vaccines against cryptosporidiosis have been developed. Control depends on understanding the dynamics of infection, in which molecular methods play a crucial role [2].

In Sweden, cryptosporidiosis has been a notifiable disease in humans since 2004. The incidence of cryptosporidiosis has increased from 0.8 cases/100,000 inhabitants in 2005 to 6.8 cases/100,000 inhabitants in 2022. The increase is attributable to, for example the development of better diagnostic tools such as multiplex PCR assays [13], as well as increased awareness and knowledge of cryptosporidiosis due to two large waterborne outbreaks that occurred in Sweden in 2010 and 2011 which affected approximately 45,000 residents [14, 15]. Several foodborne outbreaks and outbreaks associated with animal contact, including one caused by C. mortiferum in 2019, have also been reported [16,17,18,19,20,21].

In order to better understand the molecular epidemiology of human cryptosporidiosis in Sweden, a study was conducted from 2013 to 2014 involving clinical laboratories from various counties [22], followed by the implementation of a national microbiological surveillance programme for Cryptosporidium in 2018 by the Public Health Agency of Sweden (PHAS).

This article describes the results obtained through the national microbiological surveillance programme for Cryptosporidium in Sweden between 2018 and 2022.

Materials and methods

National microbiological surveillance programme

Cryptosporidium positive samples of domestically acquired infection were asked to be sent to the PHAS for typing. The primary diagnostics of cryptosporidiosis in Sweden is done by local clinical microbiological laboratories by multiplex real-time PCR and/or to a lesser extent by light microscopy, using modified Ziehl-Neelsen staining. In 2018 and 2019, samples were typed throughout the year, while in 2020 and onwards, the surveillance period and typing were changed to include samples from 1 August to 30 November.

Each Cryptosporidium positive sample included information about the age, sex and geographical location of the patient.

Molecular investigations

DNA from faecal samples was extracted using a magLEAD 12gC instrument supplied with magDEA DX MV reagents (Precision System Science Co Ltd., Chiba, Japan). All extractions were performed according to the manufacturer’s instructions. Prior to extraction, oocyst disruption was achieved by bead beating using a Bullet Blender (Techtum, Sweden). Determination of species and subtypes was done by amplification of the 60 kDa glycoprotein (gp60) gene using primers as published by Alves et al. [23] followed by bi-directional sequencing of the PCR amplicons. Unsuccessful gp60 amplification and the detection of novel subtype families were followed by amplification of the small subunit rRNA (ssu rRNA) gene by PCR, and bi-directional sequencing of the PCR amplicon [24, 25]. C. mortiferum and C. meleagridis samples were subtyped using primers, as described in Guo et al. and Stensvold et al., respectively [26, 27]. Editing and analysis of sequences was done using CLC Main Workbench (Qiagen, Aarhus, Denmark, version 8). The obtained sequences were compared to isolates in the GenBank database using the Basic Local Alignment Search Tool (BLAST; NCBI

In this article, a subtype is defined as a gp60 sequence that has a given unique subtype name. Smaller variations in the conserved non-repetitive region, that have not already been given a unique name, are considered variants of an existing subtype. These sequences are referred to by the subtype name and corresponding GenBank accession number (acc. no.) with 100% identity.

Phylogenetic analysis

Phylogenetic analysis was performed on the newly generated gp60 DNA sequences, as well as sequences from known Cryptosporidium species and subtypes. A phylogenetic tree was generated using the neighbor-joining method based on Kimura’s 2-parameter model [28]. To estimate robustness, bootstrap proportions were computed after 1000 replications. Evolutionary analyses were conducted in MEGA XI ( accessed on 2 September 2023).


Representative nucleotide sequences that were generated were submitted to the GenBank database under the following accession numbers: OL598537-OL598578, OM146534-OM146540, OM160950-OM160951, OR491772-OR491782 and OR790948-OR790949.


Case demographics

Between 2018 and 2022, 3684 cryptosporidiosis cases were reported to the national mandatory notifications system (SmiNet), of which 2639 (72%) were domestic, 950 (26%) had travel history and 95 had no information. The notification rate of domestic cryptosporidiosis from 2018 to 2022 is shown in Fig. 1A. During this period, 1850 samples were sent to the PHAS for typing and 1654 samples were further analysed. Not all samples sent for typing during the national outbreak in 2019 were analysed since a sample selection had to be made. Also, not all samples were successfully amplified. The majority of cases were annually reported between July and December, peaking in 2019 and 2022, due to national outbreaks. The age distribution of the patients is shown in Fig. 1B.

Fig. 1
figure 1

Notification rate of domestic cryptosporidiosis cases from 2018 to 2022 (A) and distribution of the submitted samples based on age groups (B)

Also, the notification rate of domestic cryptosporidiosis cases in different age groups compared to the average notification rate in the EU/EEA is shown in Supp. Figure 1.

From the submitted samples, the age range was 3 months–98 years with a mean age of 38 years. 57% of the samples were from women and 43% were from men.

Cryptosporidium species

Species determination was successful for 94% (n = 1553) of the samples and 11 different species were identified. C. parvum was detected in 91% of the samples and was thus the most common species (n = 1412). The second most common species was C. mortiferum (4%; n = 59) followed by C. hominis (3.6%; n = 56). However, no C. hominis positive samples were detected in 2020. Other less common species detected were C. erinacei (n = 11), C. cuniculus (n = 5), C. meleagridis (n = 3), C. equi (n = 2), previously known as Cryptosporidium horse genotype, C. ubiquitum (n = 2), as well as one case each of C. canis, C. ditrichi and C. felis (Table 1).

Table 1 Cryptosporidium spp. identified in Sweden from 2018 to 2022

All 21 counties in Sweden reported cases of C. parvum, while only ten reported cases of C. hominis and 13 reported cases of C. mortiferum.

The distribution of different Cryptosporidium species in different age groups is shown in Fig. 2.

Fig. 2
figure 2

Distribution of Cryptosporidium species in different age groups. C. parvum: striped, C. hominis: black, C. mortiferum: white and other species: light grey

Infection with C. parvum was more common in women (58%) than in men (41%) while infection with C. hominis and C. mortiferum was more common in men (56% in men; 44% in women and 53% in men; 43% in women, respectively).

Molecular characterisation of Cryptosporidium parvum

Seven different C. parvum subtype families (IIa, IIc, IId, IIe, IIl, IIy and IIz) were detected, of which IIy and IIz are new subtype families. The most common subtype families were IIa (n = 692) and IId (n = 663). Within the IIa subtype family, 39 different subtypes were detected, of which IIaA15G2R1 (15% of C. parvum cases), IIaA16G1R1b (12% of the C. parvum cases) and IIaA17G1R1c (5% of C. parvum cases) were the most common subtypes (Table 2).

Table 2 C. parvum subtype families and subtypes identified in Sweden from 2018 to 2022

Within subtype family IId, 22 different subtypes were detected. The most common IId subtypes were IIdA22G1c (15% of C. parvum cases), IIdA24G1 (11% of C. parvum cases) and IIdA20G1e (5% of C. parvum cases) (Table 2).

The distribution of the four most common C. parvum subtypes is shown in Fig. 3.

Fig. 3
figure 3

Distribution from 2018 to 2022 of the four most common C. parvum subtypes. Peaks in 2019 and 2022 are due to national outbreaks

The peaks of cases of IIdA22G1c and IIdA24G1 in 2019 and IIdA15G2R1 in 2022 are due to national outbreaks, whereas IIaA16G1R1b is annually one of the most common C. parvum subtypes reported but thus far has not caused any known major outbreaks between 2018 and 2022.

Of note, 11 new C. parvum subtypes were detected, IIa (n = 5), IId (n = 3), IIe (n = 1), IIy (n = 1) and IIz (n = 1). Subtype IIyA23G1R1 (OL598564) was detected in Uppsala County in 2019 and 2020 and subtype IIzA14R2 (OL598569) was detected in Västerbotten County in 2019 and 2021 and, as mentioned above, are new subtype families. The ssu rRNA sequences generated from three of the samples (OM146538) were identical to each other and to a sequence obtained from bamboo rats (MK956937). The sequences had one A to T substitution compared with C. parvum sequences commonly found in humans, cattle and other animals [29]. Further, a new subtype within the IId subtype family, IIdA7 (OR491780), which lacks TCG repeat(s) and only has 7 TCA repeats, was detected in 2022.

All subtypes and subtype variants are indicated by their respective GenBank acc. no in Table 2.

Molecular characterisation of Cryptosporidium hominis

Four different subtype families (Ia, Ib, Id and Ie) and nine different subtypes were identified. The most common subtype was IbA10G2 (56% of C. hominis cases) followed by IbA12G3 (5% of C. hominis cases) (Table 3). In addition, two new subtypes were detected, IaA16R4 (OL598578) and IaA28R3 (OL598538).

Table 3 C. hominis subtype families and subtypes identified in Sweden from 2018 to 2022

Molecular characterisation of additional species

Molecular characterisation of additional species is shown in Table 4. However, subtyping was either not successful or done for some of the cases. All cases of C. mortiferum in which subtyping was successful had subtype XIVaA20G2T1 and data concerning this species and subtype in Sweden are further presented by Bujila et al. [18]. Two new subtype families were detected, C. meleagridis IIIk with subtype IIIkA6R1 (OL598552) and C. equi VId with subtype VIdA10G1 (OL598562). The patient with IIIkA6R1 acquired the infection in 2018 and only contact with dog was reported. Genotype 2 was seen at the ssu rRNA locus (OM146536). The C. equi VId sample was further investigated at the actin, heat shock protein 70, Cryptosporidium oocyst wall protein, as well as ssu rRNA loci (OM160947, OM160948, OM160949 and OM146537, respectively). Phylogenetic analyses showed a high similarity with known C. equi sequences (data not shown). The patient acquired the infection in 2019 and no information on animal contact was obtained. The following additional new subtypes were detected: C. erinacei XIIIaA12R13 (OL598574), XIIIaA17R7 (OM160950), XIIIaA17R13 (OL598566), XIIIaA19R7 (OL598547), XIIIaA23R10 (OL598542), C. cuniculus VbA30R4 (OR491773) and C. meleagridis IIIaA20G4R (OL598544).

Table 4 Additional Cryptosporidium spp., subtype families and subtypes identified in Sweden from 2018 to 2022

Phylogenetic analysis

A phylogenetic tree that contained one representative gp60 sequence from each subtype family detected within the national surveillance programme (n = 19) was constructed (Fig. 4). Sequences from established subtype families clustered with sequences from the national surveillance programme. The new C. parvum subtype families IIy and IIz clustered with each other and IIl. The new C. meleagridis subtype family IIIk clustered with IIId and the new C. equi subtype family VId with VIb and VIa.

Fig. 4
figure 4

Phylogenetic relationships between partial gp60 Cryptosporidium DNA sequences obtained in the present study and sequences retrieved from the NCBI database. Each detected subtype family is represented by one study sample. The phylogenetic tree was constructed using the neighbor-joining method based on genetic distance calculated based on Kimura’s 2-parameter model as implemented in MEGA XI. The final dataset included 984 positions. Bootstrap values ≥ 50% from 1000 replicates are indicated at each node. New subtype families observed in this study are indicated by filled circles. All isolates from this study are indicated in bold


Several outbreaks were identified between 2018 and 2022. The majority of outbreaks were foodborne and some were due to direct contact with infected animals. Of note, no outbreaks attributed to contaminated drinking or recreational water were detected. All outbreaks except one, which was caused by C. mortiferum, were caused by infection with C. parvum (Table 5).

Table 5 Outbreaks identified in Sweden from 2018 to 2022


Cryptosporidiosis was the most common notifiable parasitic disease in Sweden in 2022 with a notification rate of 6.8/100,000 inhabitants. Regarding all notifiable diseases, it was the tenth most reported disease indicating that Cryptosporidium is relatively widespread in Sweden [30]. The notification rate of cryptosporidiosis in Sweden has increased since it became a notifiable disease in 2004 and is to be considered high in a European context: 6.8/100,000 inhabitants compared to the EU/EEA notification rate in 2022 of 3.2/100,000 inhabitants, as is also shown in Supp. Figure 1. However, notification of cryptosporidiosis in European countries and reporting to the European Surveillance System (TESSy) differs. In 2022, 24 out of the 30 EU/EEA countries reported cases, of which two countries reported zero cases [31]. The reporting of cryptosporidiosis was mandatory in 22 countries and no molecular typing data are collected and analysed at the EU/EEA level. With that in mind, the data presented in this report help to further understand the molecular epidemiology of cryptosporidiosis in Europe.

As previously mentioned, there are various reasons why the notification rate in Sweden has increased, such as better general knowledge, increased awareness, as well as the introduction of more sensitive diagnostic measures. The increasing use of multiplex assays detecting various agents, whereby clinicians do not need to specifically request diagnostics for Cryptosporidium, is also a likely cause of the increased notification rate. A study in Jönköping County in 2020 showed that cryptosporidiosis was underdiagnosed due to clinician’s choice of analysis. Cryptosporidiosis cases were detected in samples with suspected bacterial gastroenteritis but not in samples with suspected parasitic infection [13]. Similar results were found in a study of cryptosporidiosis in Denmark [32]. Thus the approach to detect cryptosporidiosis may need to change from suspicion of parasitic infection to more symptom-based diagnostics, as suggested by Ögren et al. and as a result will probably further increase the detection of cryptosporidiosis in Sweden and other countries [13].

Several reports have shown that cryptosporidiosis follows a bimodal seasonal pattern in Europe with an increase in spring and a peak in late summer/early autumn [33,34,35,36]. In Sweden, cryptosporidiosis increases in late summer and early autumn in line with observations from other European countries, but with no clear increase in cases during the spring.

Globally, cryptosporidiosis mainly affects children [33]. A characteristic of cryptosporidiosis acquired in Sweden compared to other EU/EEA countries is that the highest notification rate is not in children (0–4 years) [31]. Instead, adults (25–44 years) had the highest notification rate from 2018 onwards. Further, there is a higher proportion of C. hominis infections in children compared to other age groups.

Only a small proportion of domestically acquired cases are due to infection with C. hominis. During the COVID-19 pandemic in 2020 when travel abroad was restricted, no domestic cases of cryptosporidiosis caused by C. hominis were detected, suggesting that many infections with C. hominis are indeed contracted abroad and then occasionally causing secondary domestic transmission.

Infection with the rodent-associated C. mortiferum is considered an emerging zoonotic Cryptosporidium spp. in Sweden and the number of domestically acquired cases surpasses that of infection with C. hominis [18]. An important aspect regarding the detection of various Cryptosporidium spp. is the choice of PCR method. PCR is a highly sensitive method. However, this might not be the case for some PCRs designed to detect cryptosporidiosis. Several in-house and commercially available multiplex real-time PCR assays have been designed to detect infection by species belonging to the C. parvum/C. hominis complex. Hence, the sensitivity of species more distant from C. parvum and C. hominis is affected [37, 38]. It may give a bias in the number of detected species, as well as an underestimation in prevalence.

In accordance with the published data, the two most common C. parvum families in Sweden are IIa and IId. However, none of them are more predominant than the other. In industrialised countries, the C. parvum subtype IIaA15G2R1 is a dominant subtype in both humans and cattle [2]. This is also a relatively common subtype annually in Sweden. In 2022, it was responsible for a national foodborne outbreak. Table 2 shows other relatively common C. parvum subtypes. In summary, several C. parvum subtypes are commonly detected in Sweden. Further, many different subtypes and subtype variants of C. parvum were detected, suggesting a very high level of diversity. However, regarding the subtypes of C. mortiferum, there is a lack of diversity as all cases were subtype XIVaA20G2T1 [18]. This could possibly be attributed to the fact that to date only one natural host (red squirrel) has been detected in Sweden.

The most prevalent C. hominis subtype was IbA10G2, which is in accordance with published data [2]. Recent data have shown that IfA12G1R5 appears to have replaced IbA10G2 as the most common C. hominis subtype in the United States [39]. However, only one domestic case of this subtype has been detected in Sweden [22].

Outbreaks associated with drinking and recreational water (swimming pools) are still the main cause of outbreaks due to Cryptosporidium spp. in both Europe and the United States [33, 34]. Since the national microbiological surveillance programme for Cryptosporidium started in Sweden in 2018, no outbreaks due to contaminated water and/or infection with C. hominis have been detected. Instead, all detected outbreaks were associated with food, such as green leafy vegetables or direct contact with animals. This highlights how different kinds of food, particularly different types of lettuce are important vehicles of infection. In fact, several studies have shown contamination by Giardia duodenalis and Cryptosporidium spp. in green vegetables, as well as the detection of Cryptosporidium spp. in strawberries and raspberries [40, 41]. Food as a vehicle of infection and a source of infection warrants further investigation.


Cryptosporidiosis is the most common notifiable domestic parasitic disease in Sweden. The national microbiological surveillance programme is important and has led to increased knowledge and awareness of human cryptosporidiosis in Sweden. Cryptosporidium parvum was shown to be the dominant species causing disease, as well as outbreaks, of which only foodborne outbreaks and outbreaks associated with direct animal contact were detected. A high diversity of species and subtypes, as well as diversity within the same subtype was detected. Importantly, cryptosporidiosis is not primarily a paediatric disease in Sweden, but appears to affect adults to a great extent.

Data availability

No datasets were generated or analysed during the current study.


  1. Huang J, Chen M, He Y, Chen H, Huang M, Li N, et al. Cryptosporidium Equi n. sp. (Apicomplexa: Cryptosporidiidae): Biological and genetic characterisations. Int J Parasitol. 2023;53(10):545–54.

    Article  CAS  PubMed  Google Scholar 

  2. Ryan U, Zahedi A, Feng Y, Xiao L. An update on zoonotic Cryptosporidium species and genotypes in humans. Anim (Basel). 2021;11(11).

  3. Tumova L, Jezkova J, Prediger J, Holubova N, Sak B, Konecny R, et al. Cryptosporidium mortiferum n. sp. (Apicomplexa: Cryptosporidiidae), the species causing lethal cryptosporidiosis in eurasian red squirrels (Sciurus vulgaris). Parasit Vectors. 2023;16(1):235.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Feng Y, Ryan UM, Xiao L. Genetic diversity and Population structure of Cryptosporidium. Trends Parasitol. 2018;34(11):997–1011.

    Article  CAS  PubMed  Google Scholar 

  5. Beser J, Bujila I, Wittesjo B, Lebbad M. From mice to men: three cases of human infection with Cryptosporidium Ditrichi. Infect Genet Evol. 2020;78:104120.

    Article  CAS  PubMed  Google Scholar 

  6. Checkley W, White AC Jr., Jaganath D, Arrowood MJ, Chalmers RM, Chen XM, et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis. 2015;15(1):85–94.

    Article  PubMed  Google Scholar 

  7. Boks M, Lilja M, Widerstrom M, Karling P, Lindam A, Eriksson A, et al. Increased incidence of late-onset inflammatory bowel disease and microscopic colitis after a Cryptosporidium hominis outbreak. Scand J Gastroenterol. 2022;57(12):1443–9.

    Article  CAS  PubMed  Google Scholar 

  8. Igloi Z, Mughini-Gras L, Nic Lochlainn L, Barrasa A, Sane J, Mooij S, et al. Long-term sequelae of sporadic cryptosporidiosis: a follow-up study. Eur J Clin Microbiol Infect Dis. 2018;37(7):1377–84.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lilja M, Widerstrom M, Lindh J. Persisting post-infection symptoms 2 years after a large waterborne outbreak of Cryptosporidium hominis in northern Sweden. BMC Res Notes. 2018;11(1):625.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Rehn M, Wallensten A, Widerstrom M, Lilja M, Grunewald M, Stenmark S, et al. Post-infection symptoms following two large waterborne outbreaks of Cryptosporidium hominis in Northern Sweden, 2010–2011. BMC Public Health. 2015;15:529.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Stiff RE, Davies AP, Mason BW, Hutchings HA, Chalmers RM. Long-term health effects after resolution of acute Cryptosporidium parvum infection: a 1-year follow-up of outbreak-associated cases. J Med Microbiol. 2017;66(11):1607–11.

    Article  PubMed  Google Scholar 

  12. Carter BL, Chalmers RM, Davies AP. Health sequelae of human cryptosporidiosis in industrialised countries: a systematic review. Parasit Vectors. 2020;13(1):443.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ogren J, Dienus O, Beser J, Henningsson AJ, Matussek A. Protozoan infections are under-recognized in Swedish patients with gastrointestinal symptoms. Eur J Clin Microbiol Infect Dis. 2020;39(11):2153–60.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bjelkmar P, Hansen A, Schönning C, Bergström J, Löfdahl M, Lebbad M, et al. Early outbreak detection by linking health advice line calls to water distribution areas retrospectively demonstrated in a large waterborne outbreak of cryptosporidiosis in Sweden. BMC Public Health. 2017;17(1):328.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Widerström M, Schönning C, Lilja M, Lebbad M, Ljung T, Allestam G, et al. Large outbreak of Cryptosporidium hominis infection transmitted through the public water supply. Swed Emerg Infect Dis. 2014;20(4):581–9.

    Article  Google Scholar 

  16. Ahlinder J, Svedberg AL, Nystedt A, Dryselius R, Jacobsson K, Hagglund M, et al. Use of metagenomic microbial source tracking to investigate the source of a foodborne outbreak of cryptosporidiosis. Food Waterborne Parasitol. 2022;26:e00142.

    Article  CAS  PubMed  Google Scholar 

  17. Alsmark C, Nolskog P, Angervall AL, Toepfer M, Winiecka-Krusnell J, Bouwmeester J et al. Two outbreaks of cryptosporidiosis associated with cattle spring pasture events. Veterinary parasitology, regional studies and reports. 2018;14:71–4.

  18. Bujila I, Troell K, Fischerstrom K, Nordahl M, Killander G, Hansen A, et al. Cryptosporidium chipmunk genotype I - an emerging cause of human cryptosporidiosis in Sweden. Infect Genet Evol. 2021;92:104895.

    Article  CAS  PubMed  Google Scholar 

  19. Gherasim A, Lebbad M, Insulander M, Decraene V, Kling A, Hjertqvist M, et al. Two geographically separated food-borne outbreaks in Sweden linked by an unusual Cryptosporidium parvum subtype, October 2010. Euro Surveill. 2012;17:46.

    Article  Google Scholar 

  20. Insulander M, Silverlås C, Lebbad M, Karlsson L, Mattsson JG, Svenungsson B. Molecular epidemiology and clinical manifestations of human cryptosporidiosis in Sweden. Epidemiol Infect. 2013;141(5):1009–20.

    Article  CAS  PubMed  Google Scholar 

  21. Kinross P, Beser J, Troell K, Axén C, Björkman C, Lebbad M, et al. Cryptosporidium parvum infections in a cohort of veterinary students in Sweden. Epidemiol Infect. 2015;143(13):2748–56.

    Article  CAS  PubMed  Google Scholar 

  22. Lebbad M, Winiecka-Krusnell J, Stensvold CR, Beser J. High Diversity of Cryptosporidium Species and subtypes identified in Cryptosporidiosis Acquired in Sweden and abroad. Pathogens. 2021;10(5).

  23. Alves M, Xiao L, Sulaiman I, Lal AA, Matos O, Antunes F. Subgenotype analysis of Cryptosporidium isolates from humans, cattle, and zoo ruminants in Portugal. J Clin Microbiol. 2003;41(6):2744–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Xiao L, Bern C, Limor J, Sulaiman I, Roberts J, Checkley W, et al. Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis. 2001;183(3):492–7.

    Article  CAS  PubMed  Google Scholar 

  25. Xiao L, Morgan UM, Limor J, Escalante A, Arrowood M, Shulaw W, et al. Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl Environ Microbiol. 1999;65(8):3386–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Guo Y, Cebelinski E, Matusevich C, Alderisio KA, Lebbad M, McEvoy J, et al. Subtyping novel zoonotic pathogen Cryptosporidium chipmunk genotype I. J Clin Microbiol. 2015;53(5):1648–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Stensvold CR, Beser J, Axen C, Lebbad M. High applicability of a novel method for gp60-based subtyping of Cryptosporidium meleagridis. J Clin Microbiol. 2014;52(7):2311–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing platforms. Mol Biol Evol. 2018;35(6):1547–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Li F, Zhang Z, Hu S, Zhao W, Zhao J, Kvac M, et al. Common occurrence of divergent Cryptosporidium species and Cryptosporidium parvum subtypes in farmed bamboo rats (Rhizomys sinensis). Parasit Vectors. 2020;13(1):149.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Anmälsningspliktiga smittsamma sjukdomar i Sverige 2022.

  31. Surveillance Atlas of Infectious Diseases [cited 2023 2023-11-13].

  32. Skovgaards DM, Hartmeyer GN, Skov MN, Hoegh SV, Kemp M. Cryptosporidium species are frequently Present but rarely detected in clinical samples from children with Diarrhea in a developed country. Pediatr Infect Dis J. 2018;37(5):e138–e40.

    Article  PubMed  Google Scholar 

  33. Caccio SM, Chalmers RM. Human cryptosporidiosis in Europe. Clin Microbiol Infect. 2016;22(6):471–80.

    Article  CAS  PubMed  Google Scholar 

  34. Chalmers RM, Robinson G, Elwin K, Elson R. Analysis of the Cryptosporidium spp. and gp60 subtypes linked to human outbreaks of cryptosporidiosis in England and Wales, 2009 to 2017. Parasit Vectors. 2019;12(1):95.

    Article  PubMed  PubMed Central  Google Scholar 

  35. O’Leary JK, Blake L, Corcoran D, Elwin K, Chalmers R, Lucey B, et al. Cryptosporidium spp surveillance and epidemiology in Ireland: a longitudinal cohort study employing duplex real-time PCR based speciation of clinical cases. J Clin Pathol. 2020;73(11):758–61.

    Article  PubMed  Google Scholar 

  36. Stensvold CR, Ethelberg S, Hansen L, Sahar S, Voldstedlund M, Kemp M et al. Cryptosporidium infections in Denmark, 2010–2014. Dan Med J. 2015;62(5).

  37. Autier B, Belaz S, Razakandrainibe R, Gangneux JP, Robert-Gangneux F. Comparison of three commercial multiplex PCR assays for the diagnosis of intestinal protozoa. Parasite. 2018;25:48.

    Article  PubMed  PubMed Central  Google Scholar 

  38. van Bruijnesteijn LE, Wallinga JA, Ruijs GJ, Bruins MJ, Verweij JJ. Parasitological diagnosis combining an internally controlled real-time PCR assay for the detection of four protozoa in stool samples with a testing algorithm for microscopy. Clin Microbiol Infect. 2009;15(9):869–74.

    Article  Google Scholar 

  39. Huang W, Guo Y, Lysen C, Wang Y, Tang K, Seabolt MH, et al. Multiple introductions and recombination events underlie the emergence of a hyper-transmissible Cryptosporidium hominis subtype in the USA. Cell Host Microbe. 2023;31(1):112–23. e4.

    Article  CAS  PubMed  Google Scholar 

  40. Temesgen TT, Stigum VM, Robertson LJ. Surveillance of berries sold on the Norwegian market for parasite contamination using molecular methods. Food Microbiol. 2022;104:103980.

    Article  CAS  PubMed  Google Scholar 

  41. Trelis M, Saez-Duran S, Puchades P, Castro N, Miquel A, Gozalbo M, et al. Survey of the occurrence of Giardia duodenalis cysts and Cryptosporidium spp. oocysts in green leafy vegetables marketed in the city of Valencia (Spain). Int J Food Microbiol. 2022;379:109847.

    Article  CAS  PubMed  Google Scholar 

Download references


The authors are grateful to all the microbiological laboratories in Sweden that provided samples to the national microbiological surveillance programme for Cryptosporidium and all the regional departments of communicable disease control. The authors are also grateful to Marie Jansson Mörk from the Department of Communicable Disease Control and Health Protection at the PHAS for initial statistical help.


This work was funded by the administrative grant of the Public Health Agency of Sweden.

Author information

Authors and Affiliations



IB, ML and JB drafted the manuscript. IB, GK and LA contributed to the laboratory analysis. IB, AH, ML and JB contributed to the acquisition, analysis or interpretation of data. KT and JO contributed to critical revision of the manuscript as well as to its intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ioana Bujila.

Ethics declarations

Ethics approval and informed consent

This work was performed in accordance with the Swedish Disease Act (2004:168) and part of the Public Health Agency of Sweden assignment to monitor communicable diseases and evaluate infection control measures in accordance with Sect. 18 of the ordinance (2021:248) issued by the Swedish Parliament. For this reason, specific ethical clearance and informed consent is not required for the results presented from the national surveillance programme for Cryptosporidium.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bujila, I., Troell, K., Ögren, J. et al. Cryptosporidium species and subtypes identified in human domestic cases through the national microbiological surveillance programme in Sweden from 2018 to 2022. BMC Infect Dis 24, 146 (2024).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: